Leading enterprise of Chinese medicine major health dream blocked to go upstream is the solution

A few days ago (July 2), the third Chinese brand Pharmaceutical Enterprise Salon (hereinafter referred to as APS) held in Qingdao, from Donga donkey-hide gelatin, tasly, Yunnan white powder, Jiang Zhong Pharmaceutical, 39 medical trade, Yunnan Rainbow Pharmaceutical, Sig pharmaceutical industry, the relevant responsible person and a number of industry participants attended the salon. It is reported that the APS organization by Dong Donkey-hide gelatin, Jiang in the pharmaceutical, tasly, Yunnan white powder, 395 domestic brand pharmaceutical companies launched in April 2010, the use of the rotating system, held two times a year. At the end of last year and at this salon, the Yunnan Rainbow Pharmaceutical and Sig pharmaceutical industry successively joined the APS organization.　　Since then, the APS organization has included 7 domestic brands of Chinese medicine enterprises. The current President Donga Donkey-Hide gelatin general Manager Qin keynote speech coincidentally, the current 7 members have their future locked in the big health industry. One to promote the health of all people, to ensure the safety of medication for the potters, the above downstream industrial chain extension, category expansion for the means of the big health dream has been embryonic. Take the current APS rotating president, Donga Donkey-Hide gelatin general Manager Qin said as an example: "In recent years, the product level of Donga gelatin is increasingly clear, the" drug-health care-food "development strategy, in addition to ensure that the compound donkey-hide gelatin in the field of OTC and high-end medical benefits to the people, but also through the Peach Huaji, donkey-hide and other related in this context," The raw material is the first workshop "The argument is surging, the medicine enterprise has to March upstream, through self-built or the cooperative way expands the raw material base." A case of donkey-hide-gelatin, east, has been in Xinjiang, Inner Mongolia, Gansu, Shandong, Liaoning and other land set up 13 donkey base, plan to the end of 2015, the cumulative establishment of donkey base not less than 20. But it is limited by many factors, such as capital, land, planting habit, regional policy and so on.　　　　But because the information asymmetry, the circulation industry chain is long, lacks the scientific research support and so on causes the medicinal material price fluctuation, the circulation cost is too big, the planting standardization degree low question also is puzzling the medicine enterprise. Fortunately, branded pharmaceutical companies are interested in working together to make a difference. "APS organization can be the first to try to cooperate, through the construction of raw materials base, and jointly build a reserve trading platform to effectively fundamentally ensure the safety of raw materials?" "At this APs, the rotating President Qin is trying to find a way to solve the problem of raw materials." The proposal was widely accepted by the participants.　　At the meeting, 7 APS Enterprises signed a memorandum of cooperation, said will be "Chinese herbal medicine planting base and the construction of provenance", "Chinese herbal medicine planting technology research and development, training and the cultivation of farmers input", "Chinese Medicine raw materials Reserve and trading platform for the construction of" "self-care, civic health market atmosphere to create" and other aspects of cooperation.　　It is reported that 7 companies will be represented after the meeting, as soon as possible to set up a working group to specifically agree on the location of the base construction and cooperation details, and the results of the cooperation is expected to surface in the year.　　The development of health food has benefited more consumers from gelatin. Donga Donkey-hide-gelatin, tasly, Yunnan white powder and other 7 pharmaceutical enterprise executives share the difficulties of raw materials and Yunnan White Medicine and Yunnan Rainbow Pharmaceutical industryThe extension of SIG, the extension of the pharmaceutical industry through the expansion of the upstream industry movements, tasly "health care Products" and "Health management services Industry" and a series of events have shown the brand drug companies want to be in the big health cause of a fist. Guo Zhenyu, chairman of Yunnan Rainbow Pharmaceutical Co., said this large health map of the target is the promotion of civic health awareness, and APS should give full play to the organization's brand effect, popularize civic health awareness, promote the concept of correct drug use, but also can promise to consumers, as long as the APS members of the production of drugs, it must be a safe medicine,　　It's a safety pill. Schen, in the brand drug companies in the big health map of the time, but encountered a stumbling block-raw material problems.　　This has also become the focus of discussion among members of this APS. Data show that since the second half of 2009, due to the weather, hot money speculation, inflation and a series of reasons, Chinese herbal medicines into the rising channel, to 2010 the national 537 kinds of Chinese herbal medicines a total of 84% price increases, from 10% to 400%.　　This momentum has not yet been curbed and has ushered in the seventh tide. 7 Pharmaceutical companies signed a memorandum of cooperation to jointly deal with the price of raw materials